A new analysis of more than 50 previously secret, corporate-backed scientific studies is raising troubling questions about a history of regulatory reliance on such research in assessing the safety of the widely used weedkilling chemical known as glyphosate, the key ingredient in the popular Roundup herbicide.
In a 187-page report released on Friday, researchers from the Institute of Cancer Research at the Medical University of Vienna in Austria said a thorough review of 53 safety studies submitted to regulators by large chemical companies showed that most do not comply with modern international standards for scientific rigor, and lack the types of tests most able to detect cancer risks.Read More
An elderly California woman who was a regular user of Monsanto’s Roundup weed killer for more than 30 years is set as the next person to try to prove that exposure to the chemical causes non-Hodgkin lymphoma, a claim already won by plaintiffs in three previous trials.
The case of Donnetta Stephens v. Monsanto is set for trial July 19 in San Bernardino County Superior Court in California. Stephens from Yucaipa, California was diagnosed with non-Hodgkin lymphoma (NHL) in 2017 and has suffered from numerous health complications amid multiple rounds of chemotherapy since then. Because of her poor health, a judge in December granted Stephens a trial “preference,” meaning her case was expedited, after her lawyers informed the court that Stephens is “in a perpetual state of pain,” and losing cognition and memory.
Several other cases have either already been granted preference trial dates or are seeking trial dates for other plaintiffs, including at least two children, suffering from NHL the plaintiffs allege was caused by exposure to Roundup products.Read More
For years, the people of Mead, Nebraska, have worried about the ethanol plant that moved into their small rural community a little over a decade ago. They feared the terrible smells and odd illnesses in the area might be connected to the plant and its use of pesticide-coated seed corn in its biofuel production process.
Those concerns recently turned to outrage and anger after environmental regulators were forced to acknowledge that under their oversight the AltEn LLC ethanol plant has been contaminating the area with an array of pesticides at levels much higher than what is considered safe.
The contamination has been ongoing for years, exacerbated through accidental spills and leaks of the plant’s pesticide-laden waste, which has been stored in poorly maintained lagoons and piled into hills of a putrid lime-green mash called “wet cake”. The company had also distributed the waste to area farmers for spreading across fields as “soil conditioner”.
It was only earlier this year – after media reports exposed the problems – that state officials ordered the plant to close, and began efforts to clean up what many in the community see as a sprawling environmental disaster.
The state attorney general’s office then sued the company for multiple alleged environmental violations, citing “an ongoing threat to the environment”, and late last month Nebraska lawmakers passed a bill restricting the use of pesticide-treated seeds for ethanol production.
Residents of Mead say the crackdown on the plant is welcomed, but, in many respects, is far too late. The lingering impact of the pollution won’t simply end with the new law, nor will many of the industrial agriculture practices that caused it. Instead, the pollution continues to wreak havoc and there are fears that Mead’s trauma may be repeated in other small towns across the state where large-scale industrial agriculture practices continue.Read More
A highly anticipated first-ever trial pitting a group of farmers against the global agricultural giant Syngenta AG over allegations that Syngenta’s paraquat weed killer causes Parkinson’s disease has been delayed again and may not take place at all, according to sources close to the case.
The trial in the case of Hoffman V. Syngenta was scheduled to start June 1 in St. Clair County Circuit Court in Illinois before Associate Judge Kevin Hoerner. Previously it was set to begin May 10, and prior to that it had a trial date in April.
The cancellation of the June 1 trial date came amid speculation that the parties are deep into settlement talks. No new trial date has yet been set, according to a St. Clair County Circuit Court clerk.Read More
The federal judge overseeing nationwide Roundup litigation on Wednesday denied Bayer’s latest attempt to limit its legal liability from future cancer claims associated with its glyphosate-based herbicides, citing numerous “glaring flaws” in a settlement proposed to apply to Roundup users who have not yet sued the company but may want to do so in the future.
Saying parts of the plan were “clearly unreasonable” and unfair to cancer sufferers who would be part of the class settlement, U.S. Judge Vince Chhabria castigated Bayer and the small group of lawyers who put the plan together in conjunction with Bayer.
He pointed out that the company has been “losing trials left and right” in claims brought by people suffering from non-Hodgkin lymphoma (NHL) who alleged exposure to Monsanto’s Roundup and other glyphosate-based herbicides were the cause.
Bayer has owned Monsanto since 2018 and has been struggling to defend the cancer claims ever since. Cancer victims have won three trials held to date, and tens of thousands of other plaintiffs have filed lawsuits alleging exposure to Monsanto’s herbicides caused them to develop NHL while Monsanto spent decades hiding the risks.Read More
As Bayer AG works to put an end to costly litigation over alleged connections between Roundup herbicide and cancer, the company faces a critical hearing on Wednesday in federal court in San Francisco.
At issue in the hearing is a proposed $2 billion class action settlement structured by Bayer in coordination with a small team of plaintiffs’ lawyers as a means to address potential future lawsuits.
Proponents of the proposed class action plan say it “will save lives,” and provide “speedy compensation” to people who get NHL.
But the plan has generated widespread opposition from law firms around the country who say the proposal actually does little for cancer patients while benefiting Bayer and the lawyers who structured the proposal and who will be paid millions of dollars in fees if the plan goes through.
The class action settlement would apply to people exposed to Roundup products as of Feb. 3, 2021 who have not yet sued Monsanto or retained a lawyer to do so. The settlement plan would set up a framework for addressing new claims brought by those exposed individuals who develop non-Hodgkin lymphoma (NHL) they attribute to their Roundup exposure.
The class action plan, which is separate from an $11 billion settlement of Roundup litigation announced by Bayer last June to address already filed lawsuits, needs approval from U.S. District Judge Vince Chhabria. A prior class action settlement plan submitted last year was scorned by Chhabria and then withdrawn. The judge has been overseeing the federal multidistrict Roundup litigation involving thousands of plaintiffs from around the United States.
On Tuesday, Judge Chhabria issued a pretrial order stating that Wednesday’s hearing “will focus on big-picture concerns” with the proposed settlement.Read More
A highly anticipated first-ever trial pitting a group of farmers against the global agricultural giant Syngenta AG over allegations that Syngenta’s paraquat weed killer causes Parkinson’s disease has been delayed until June, the parties involved said on Saturday.
The trial was set to begin Monday, livestreamed by Courtroom View Network, but a continuance was ordered setting a new trial date for June 1. A spokesman for the plaintiffs’ legal team said the delay was not due to any settlement efforts, but due to “a combination of scheduling and Covid issues.”
The case is titled Hoffman V. Syngenta and is set for a bench trial in St. Clair County Circuit Court in Illinois before Associate Judge Kevin Hoerner.
The plaintiffs are farmers who developed Parkinson’s after repeated exposure to paraquat products, specifically Syngenta’s widely used Gramoxone brand, and the spouses of those farmers. Three of the original plaintiffs in the case have died, including plaintiff Thomas Hoffman.Read More
Six more lawsuits alleging Syngenta’s weed killing pesticide paraquat causes Parkinson’s Disease were filed last week in Pennsylvania, California and Illinois, adding to more than a dozen similar lawsuits already filed in U.S. courts.
The lawsuits all allege that exposure to paraquat, which is banned in more than 30 countries though not in the United States, causes the incurable and progressive Parkinson’s disorder that affects nerve cells in the brain, leading in advanced cases to severe physical debilitation and often dementia and death.
Many Parkinson’s experts say the disease can be caused by a range of factors, including exposure to pesticides such as paraquat, as well as other chemicals.
The first trial set to take place in the United States is to begin on May 10 in St. Clair County Circuit Court in Illinois. Missouri lawyer Steve Tillery is representing the plaintiffs in Hoffman V. Syngenta and said he plans to introduce evidence that includes internal company records showing Syngenta has known for decades that its product causes Parkinson’s Disease.Read More
The lawyers who led the nationwide U.S. Roundup litigation through three trial victories and forced Monsanto owner Bayer AG into an $11 billion settlement have notified a federal court that they have uncovered evidence of fraud in a secret deal between Monsanto and a lone plaintiff’s lawyer who has not been active in the litigation until recently.
In a series of filings made Thursday with the U.S. Court of Appeals for the 11th Circuit, lawyers from three firms involved in the three successful Roundup trials alerted the court to what they said was an effort by Monsanto to “buy” a favorable appellate court ruling.
The agreement between Monsanto and one plaintiff and his attorney is a “pay-to-appeal scheme,” according to plaintiffs’ lawyers Aimee Wagstaff, Brent Wisner and Jennifer Moore. The legal team asks the court to dismiss the appeal they allege is the focus of the scheme.
The lawyer involved in cutting the deal with Monsanto is Ashleigh Madison of Southeast Law LLC in Savannah, Georgia. Madison confirmed various terms of the arrangement with Monsanto to Wagstaff’s firm in an email and phone conversations recounted in a declaration, according to the filings made Thursday.
When contacted for comment, Madison denied the allegations and said her client’s best interests are her “top priority.” She said she looks “forward to further addressing the matter before a court of law, as our system of justice intends.”Read More
A new research report shows health problems linked to the long-banned insecticide DDT have persisted across at least three generations, affecting even the granddaughters of women exposed to the chemical in the 1960s.
The research, which was published April 14 in the Cancer Epidemiology, Biomarkers & Prevention Journal, is the latest in a series of findings generated from a relatively unique study that began in the 1960s, when DDT was widely used. Researchers obtained blood samples from women in their third trimester of pregnancy and also just after they gave birth to determine their DDT exposure. More than 15,000 women seeking obstetric care at the Kaiser Foundation Health Plan in the San Francisco Bay Area from 1959 to 1967 were included in the original study.Read More